---
schema_version: "secwatch.filing_event.v1"
accession: "0001370053-25-000014"
form_type: "8-K"
ticker: "ANAB"
cik: "0001370053"
company_name: "ANAPTYSBIO, INC"
filed_at: "2025-02-19T23:59:59+00:00"
generated_at: "2026-05-26T10:48:46.544652+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# AnaptysBio updates corporate investor presentation; details not available from filing

## Summary
- Filing indicates updated February 2025 corporate presentation, but full content not provided in extract.
- No specific financial or pipeline updates disclosed in the filing text or the partial exhibit.
- Presentation typically covers strategic overview; no material numbers or events are reported.
- Investors should refer to the full presentation on the company website for details.

## SEC filing metadata
- accession: 0001370053-25-000014
- form_type: 8-K
- ticker: ANAB
- cik: 0001370053
- company_name: ANAPTYSBIO, INC
- filed_at: 2025-02-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1370053/000137005325000014/0001370053-25-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1370053/000137005325000014/anab-20250219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001370053-25-000014
- JSON: https://secwatch.observer/filing/0001370053-25-000014.json
- Plain text: https://secwatch.observer/filing/0001370053-25-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.